NCT02474680View on ClinicalTrials.gov

Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions
Major Depressive Disorder 1
Interventions
GENETIC

Pharmacogenetic testing

Psychotropic genotyping panel

Trial Locations (1)

57108

Avera Institute for Human Genetics, Sioux Falls

All Listed Sponsors
lead

Avera McKennan Hospital & University Health Center

OTHER

NCT02474680 - Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes | Biotech Hunter | Biotech Hunter